News & Opinion

Brisbane hosts global health leaders in fight against antibiotic resistance

March 31, 2017

Global leaders in the fight against antibiotic resistance will gather in Brisbane next week (3-5 April) for the University of Queensland-hosted Solutions for Drug-Resistant Infections (SDRI) conference. UQ Institute for Molecular Bioscience (IMB) Centre for Superbug Solutions researcher Dr Mark Blaskovich said integrating global research efforts and expertise was critical for saving lives. Read more

Read More

SPHERE – $20 million collaboration to capture clinical innovation

March 30, 2017

A $20 million partnership between 14 leaders in health, education and medical research in NSW was launched in Sydney today by the NSW Minister for Health and Medical Research, Brad Hazzard. The Sydney Partnership for Health, Education, Research and Enterprise (SPHERE) is a collaboration between leading experts in health, research and education sectors and aims…

Read More

Study: Colorectal cancer patients with certain genetic mutations may benefit more from aspirin

March 30, 2017

Colorectal cancer patients with certain genetic backgrounds may benefit more from taking aspirin to prevent cancer reoccurrence, based on a study conducted by researchers at the Baylor Scott & White Health Research Institute. The study, published this month in Cancer Prevention Research, examined how aspirin influences the growth of cultured colorectal cancer cells with a…

Read More

New genetic causes of ovarian cancer found

March 27, 2017

A dozen new genetic variants that increase women’s risk of ovarian cancer have been discovered by a team of international researchers. These are essential new clues about the “wiring” of a disease that will claim the lives of an estimated 1,050 Australian women in 2017, says Australian oncologist Associate Professor Clare Scott from the Royal…

Read More

Gisborne trial reveals weight loss from plant-based diet

March 27, 2017

With the highest obesity and Type 2 Diabetes rates in the country, Gisborne has been subject of successful new dietary study. MEDICAL research published this week in Nutrition & Diabetes journal shows Gisborne participants lost an average 11.5kg in one year, the largest weight loss of any randomised control trial where participants had no restriction…

Read More

DNA ‘typos’ may cause 66% of cancer mutations

March 27, 2017

Random, unpredictable DNA copying mistakes account for nearly two-thirds of the genetic changes that cause cancer—far more mutations than those triggered by heredity or by environmental factors like smoking or pollution, a study finds. The study used a new mathematical model based on DNA sequencing and epidemiologic data from around the world. The findings do…

Read More

Autism research leads to start-up

March 27, 2017

A new company spun out of Deakin and The Florey Institute of Neuroscience and Mental Health will explore the potential of promising new autism treatments. Autism Spectrum Disorder (ASD) is one of the most significant neurological conditions affecting children and their families, with approximately one in 100 people diagnosed with the disorder. While ASD is…

Read More

Malaghan ties the knot with China for cancer vaccine trials

March 27, 2017

Kiwis are being guaranteed the first bite at new cancer vaccines set to be developed and trialled on our shores through Wellington’s Malaghan Institute of Medical Research. The venture, aimed at developing vaccine based immunotherapy treatments, was formalised today in an agreement with Chinese researchers. Wellington Zhaotai Therapies has been formed for the venture, with a focus on transfusion-style…

Read More

World-first liquid biopsy for blood cancers promises less invasive, more precise and effective treatments

March 27, 2017

12,000+ Australians diagnosed with blood cancers each year could soon have access to a simple blood test to monitor their disease thanks to a world-first ‘liquid biopsy’ developed at Peter MacCallum Cancer Centre. The liquid biopsy for blood cancers developed by Associate Professor Sarah-Jane Dawson and Professor Mark Dawson, promises a new era of less…

Read More

Drug could slow motor neuron disease

March 27, 2017

A drug with the potential to delay the progression of motor neuron disease (MND) could be in human trials within three years. University of Queensland researchers have shown the anti-inflammatory drug PMX205 is effective in animals with the disease, delaying the progression of symptoms and extending survival. Read more

Read More

Upcoming Events